S.P. Pasechnikov, M.D. Dyachuk

Analysis of complications after laser vaporization apparatus modified Medilas Dornier Urobeam 940 nm, transurethral resection of prostate and open surgical treatment of benign prostatic hyperplasia

In the work was the analysis of complications of endoscopic and open methods of surgical treatment of patients with benign prostatic hyperplasia. Evaluated the results of surgical treatment of 180 patients with BPH aged 50 to 86 years (average was 69.7 years). The inclusion criterion was the presence Pacino first found out and objectively by docosanol BPH with violation of urination, which is subject to surgical treatment (IPSS > 8).

All the studied patients were divided into groups as follows: group 1 - patients with perspectacles gland volume of less than 80 ml, which is made of laser vaporization of the prostate (n = 31); group 2 - patients with a prostate volume of less than 80 ml who underwent TUR of the prostate (n = 40); group 3 - patients with prostate volume over 80 ml, which was made open prostatectomy (n = 40), group 4 - patients with a prostate volume of less than 80 ml, who underwent a modified laser vaporization of the prostate (n = 33) and group 5 - patients with a prostate volume more than 80 ml (n = 36) who also performed a modified laser vaporization of the prostate.

It is established that modifided laser vaporization of the prostate with Urobeam the Dornier Medilas apparatus 940 nm, regardless of the size of the prostate is accompanied by the lowest number of postoperative complications, likely not differing on this indicator from TUR of the prostate and 1.6 times significantly less than when the TUR show out prostate complications of II-III stage on the scale of Clavien-Dindo, including imperative urination disorders, urinary incontinence, hemotamponade, bladder neck stenosis, urethral stricture.